You are here
Improving Resilience and Equity in Cervical Cancer Screening: Lessons from COVID-19 and Beyond
Overview
November 9 & November 10, 2020
Meeting Outcomes
- Stakeholder input on opportunities, barriers, and possible solutions to improve cervical cancer screening during and post COVID-19
- Stakeholder input on barriers included in cross-cutting theme areas
Agenda
November 9, 2020
|
1:00-1:10 |
Agenda Review and Administrative Statements Administrative remarks, facilitator introduces agenda and process |
|
|
1:10 – 2:00 |
PCP Working Group Introduction and Presentation PCP introduction, introduce the working team and present work to date on the landscape of opportunities, barriers, and possible solutions
|
|
|
2:00 – 3:00 |
Cervical Cancer Screening Improvement Opportunities Session 1: Prioritize Inclusion of HPV Testing in Screening
|
|
|
3:00 – 3:15 |
Break |
|
|
3:15 – 4:15 |
Cervical Cancer Screening Improvement Opportunities Session 2: HPV Self-Sampling to Increase Access for Underserved Populations Opportunities to improve screening, associated barriers, and possible solutions
|
|
|
4:15 – 4:35 |
Working Group Review of Input and Final Comments Review of the day’s stakeholder input and reactions to day’s work
|
|
|
4:35 – 5:00 |
Review of Input and Final Comments Review of the day’s stakeholder input and reactions to day’s work
|
|
November 10, 2020
|
1:00-1:15 |
Agenda Review and Administrative Statements Administrative remarks, facilitator introduces agenda and process, reflections from day 1 |
|
|
1:15 – 2:15 |
Cervical Cancer Screening Improvement Opportunities Session 3: Using Technology to Improve Screening Management, and Communication with Patients Opportunities to improve screening, associated barriers, and possible solutions
|
|
|
2:15 – 3:15 |
Cervical Cancer Screening Improvement Opportunities Session 4: Risk Based Approach to Screening and Management Opportunities to improve screening, associated barriers, and possible solutions
|
|
|
3:15 – 3:30 |
Break |
|
|
3:30 – 4:30 |
Cervical Cancer Screening Improvement Opportunities Session 5: Reduce SARs-CoV-2 Infection Risk in Clinical Settings Opportunities to improve screening, associated barriers, and possible solutions
|
|
|
4:30 – 4:40 |
Panel Final Comments Brief review of input and panel discussion of next steps
|
|
|
4:40 – 5:00 |
Response to Public Questions and Comments |
|
Participants
Deborah Arrindell
Vice President, Health Policy
American Sexual Health Association
Silver Spring, MD
Jessica L. Bienstock, MD, MPH
Associate Dean for Graduate Medical Education
Professor of Gynecology and Obstetrics
Johns Hopkins University School of Medicine
Baltimore, MD
Haywood Brown, MD
Vice President, Institutional Equity Associate Dean
Morsani College of Medicine
Professor of Obstetrics and Gynecology
Division of Maternal-Fetal Medicine
University of South Florida Tampa, FL
David Chelmow, MD
Leo J. Dunn Professor and Chair Department of Obstetrics and Gynecology
Virginia Commonwealth School of Medicine
Richmond, VA
Andrew Crighton, MD
Chief Executive Officer
Roundtable on Cancer and Project Data Sphere
Morrisville, NC
Barbara Crothers, DO
Associate Professor of Pathology
Consultant, Cytology, Gynecology, and Breast Pathology
Joint Pathology Center
Uniformed Services University of the Health Sciences
Silver Spring, MD
Katherine Dallow, MD
Vice President and Medical Director, Clinical Programs and Strategy
Health and Medical Management
Blue Cross and Blue Shield of Massachusetts
Quincy, MA
Tamika Felder
Chief Visionary Cervivor
Upper Marlboro, MD
Lisa Flowers, MD
Professor, Department of Gynecology and Obstetrics
Director, Colposcopy and Anoscopy
Emory University School of Medicine
Atlanta, GA
Holly B. Fontenot, PhD, RN/NP
Associate Professor and Frances A. Mastuda Chair in Women's Health
University of Hawaii at Manoa School of Nursing
Honolulu, HI
Francisco García, MD, MPH
Deputy County Administrator for Health & Community Services
Chief Medical Officer, Pima County
Tucson, AZ
Richard Guido, MD
Professor, Obstetrics and Gynecology
University of Pittsburgh, Magee-Women’s Hospital
Pittsburgh, PA
Aimee C. Holland, DNP, WHNP- BC, FNP-C, FAANP
Associate Professor Assistant Dean for Graduate Clinical Education
University of Alabama, Birmingham School of Nursing
Birmingham, AL
Warner K. Huh, MD
Professor and Margaret Cameron Spain Endowed Chair Department of Obstetrics and Gynecology
University of Alabama, Birmingham
Birmingham, AL
Robert A. Ingram
Member, President’s Cancer Panel
General Partner, Hatteras Venture Partners
Durham, NC
Maureen R. Johnson, PhD
Executive Secretary, President’s Cancer Panel
Special Assistant, Office of the Director
National Cancer Institute
National Institutes of Health
Bethesda, MD
Thomas S. Lorey, MD
Strategic Director, National Integrated Services
Kaiser Permanente Northern California Region
The Permanente Medical Group, Inc.
Berkeley, CA
William C. Louv, PhD
President, Project Data Sphere
CEO, Roundtable on Cancer
Morrisville, NC
L. Stewart Massad, MD
Professor of Gynecologic Oncology
Department of Obstetrics and Gynecology
Washington University
St Louis, MO
Edith P. Mitchell, MD, MACP, FCPP
Member, President’s Cancer Panel
Clinical Professor of Medicine and Medical Oncology, Department of Medical Oncology
Director, Center to Eliminate Health Disparities
Associate Director of Diversity Affairs, Sidney Kimmel Cancer Center
Thomas Jefferson University
Philadelphia, PA
Karen L. Parker, PhD
Director
Sexual and Gender Minority Research Office
National Institutes of Health
Bethesda, MD
Rebecca Perkins, MD
Associate Professor of Obstetrics and Gynecology
Boston University School of Medicine/ Boston Medical Center
Boston, MA
Mona Saraiya, MD, MPH
Medical Officer and Team Lead, Epidemiology and Applied Research Branch
Division of Cancer Prevention and Control
Centers for Disease Control and Prevention
Atlanta, GA
Debbie Saslow, PhD
Managing Director
HPV & GYN Cancers
American Cancer Society
Atlanta, GA
Mark Schiffman, MD, MPH
Senior Investigator
Division of Cancer Epidemiology and Genetics
National Cancer Institute
Rockville, MD
Jane Segebrecht, MPH
Strategic Initiatives Lead, Office of Women’s Health
Health Resources and Services Administration
U.S. Department of Health and Human Services
Rockville, MD
Robert A. Smith, PhD
Senior Vice President, Cancer Screening
Cancer Prevention and Early Detection
American Cancer Society
Mark H. Stoler, MD
Professor (Emeritus) of Pathology and Clinical Gynecology, Department of Pathology
University of Virginia Health System
Charlottesville, VA
Sherrie Flynt Wallington, PhD
Assistant Professor, Health Disparities and Oncology
George Washington University School of Nursing
Washington, DC
Nicolas Wentzensen, MD, PhD, MS
Senior Investigator
Head, Clinical Epidemiology Unit Deputy Chief, Clinical Genetics Branch
Division of Cancer Epidemiology and Genetics
National Cancer Institute
Bethesda, MD
John P. Williams, MD, FACS
Chair, President’s Cancer Panel
Medical Director, Breast Cancer School for Patients
Gainesville, VA
Amy L. Wiser, MD
Assistant Professor and Curriculum Director Undergraduate Medical Education
Oregon Health & Science University
Portland, OR
Luna Zaritsky, PhD
Biologist
U.S. Food and Drug Administration
Silver Spring, MD